Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Person › Details

Gil Beyen (TiGenix N.V. (Euronext + Nasdaq: TIG))

Beyen, Gil (Erytech 2012– CEO before TiGenix 201112 CBO + before CEO + Co-founder)

 

Organisation Organisation TiGenix N.V. (Euronext + Nasdaq: TIG)
  Group Takeda (Group)
Products Product cancer drug
  Product 2 cell therapy
     

   
Record changed: 2021-01-05

Advertisement

Picture [iito] Made Without Love 650x80px


More documents for Gil Beyen


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top